Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
University of Nebraska
Adela, Inc
Mayo Clinic
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
LigaChem Biosciences, Inc.
PharmaMar
Tempus AI
University of South Florida
Universidade Federal de Pernambuco
Aminex Therapeutics, Inc.
Prelude Therapeutics
Avera McKennan Hospital & University Health Center
Technische Universität Dresden
Gilead Sciences
Hospices Civils de Lyon
CureOne
University of Southern California
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
Pharmacyclics LLC.